trending Market Intelligence /marketintelligence/en/news-insights/trending/QE_nHrYxALXOP9lu4r42sw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Novartis sells Indian rights to some medicine brands

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Novartis sells Indian rights to some medicine brands

Novartis AG sold the Indian rights to some of its medicine brands to Mauritius-based private equity firm Samara Capital Inc., a company spokesperson said.

The sale includes the rights to Cofvector, Monkezin and Glyred along with exclusive licenses to Curam, Foristal and Gretacal.

The financial terms of the deal were not disclosed.